PDT Partners’s Meridian Bioscience Inc VIVO Stock Holding History

PDT Partners’s Portfolio VIVO Stock Details VIVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-14,261	Closed	-$291K	–	1172
2021 Q4	$291K	Buy	+14,261	New	+$273K	0.02%	678
2020 Q4	–	Sell	-26,768	Closed	-$455K	–	890
2020 Q3	$455K	Buy	+26,768	New	+$520K	0.03%	467
2015 Q3	–	Sell	-10,643	Closed	-$198K	–	1653
2015 Q2	$198K	Sell	10,643 -7,017	-40%	-$130K	0.01%	1241
2015 Q1	$337K	Buy	+17,660	New	+$327K	0.01%	1127
2014 Q4	–	Sell	-22,933	Closed	-$406K	–	1181
2014 Q3	$406K	Buy	+22,933	New	+$451K	0.01%	1007
2014 Q2	–	Sell	-54,708	Closed	-$1.19M	–	1711
2014 Q1	$1.19M	Buy	+54,708	New	+$1.25M	0.03%	623
2013 Q4	–	Sell	-30,736	Closed	-$727K	–	1250
2013 Q3	$727K	Buy	+30,736	New	+$718K	0.02%	896

Other funds holding VIVO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Impactive Capital New York City, New York $1.38B AUM 1.92% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VLKIM

Van Lanschot Kempen Investment Management Amsterdam, Netherlands $11.4B AUM 16.77% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

PDT Partners's VIVO Position: Q1 2022 in Review

PDT Partners sold out of Meridian Bioscience Inc (VIVO) in Q1 2022, closing a stake of 14,261 shares — an estimated $291K sold.

PDT Partners first reported a position in VIVO in Q3 2013 and held it in 7 quarters. The position peaked at $1.19M in Q1 2014. 210 funds tracked by Wall St. Rank hold VIVO as of Q1 2022.

PDT Partners reported no remaining Meridian Bioscience Inc position as of Q1 2022 after selling out during the quarter.
PDT Partners sold 14,261 Meridian Bioscience Inc shares in Q1 2022, an estimated $291K.
PDT Partners first reported a position in Meridian Bioscience Inc in Q3 2013 and held it in 7 quarters.
PDT Partners's Meridian Bioscience Inc position peaked at $1.19M in Q1 2014.
210 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q1 2022.

Based on PDT Partners's 13F filing for Q1 2022, filed 16 May 2022.